CVI Investments, Inc. - 30 Jun 2025 SCHEDULE 13G/A Report for Reviva Pharmaceuticals Holdings, Inc. Common Stock, $0.0001 par value per share (RVPH)

Filing Manager
CVI Investments, Inc.
Reporting Manager
CVI Investments, Inc.
Security
Reviva Pharmaceuticals Holdings, Inc. Common Stock, $0.0001 par value per share
Symbol
RVPH
Shares outstanding
72,889,857 shares
Disclosed Ownership
3,571,603 shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 14:01:45 UTC
Date of event
30 Jun 2025
Previous filing
01 Jul 2025
Next filing
25 Mar 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"CVI Investments, Inc. disclosed 4.9% ownership in Reviva Pharmaceuticals Holdings, Inc. Common Stock, $0.0001 par value per share (RVPH) on 30 Jun 2025."

Quick Takeaways

  • CVI Investments, Inc. filed SCHEDULE 13G/A for Reviva Pharmaceuticals Holdings, Inc. Common Stock, $0.0001 par value per share (RVPH).
  • Disclosed ownership: 4.9%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 01 Jul 2025.
  • Current filing was accepted on 14 Aug 2025, 14:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
CVI Investments, Inc. 4.9% 3,571,603 0 3,571,603 /s/ Sarah Travis Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Heights Capital Management, Inc. 4.9% 3,571,603 0 3,571,603 /s/ Sarah Travis Sarah Travis, Assistant General Counsel and Assistant Secretary

Sponsored